Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Celldex Therapeutics, Inc.

NASDAQ: CLDXHealthcare / Biotechnology / USA
0.2700+0.0100+3.85%Vol 5 162 6961Y Perf -89.79%
Jan 16th, 2019 16:00
BID0.2700 ASK0.2700
Open0.2600 Previous Close0.2600
Pre-Market- After-Trading-
 - -%  - -%
Target Price
2.15 
Analyst Rating
Moderate Buy 2.00
Potencial %
696.30 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
★★★★     58.25
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)47 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
3.31 
Earnings Date
6th Mar 2019

Today's Price Range

0.26000.3200

 

52wk Range

0.18002.90

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
12.50%
3 Months
-38.64%
6 Months
-48.08%
1 Year
-89.79%
3 Years
-97.58%
5 Years
-99.05%

Quotes

Name / TickerPriceChg.Chg.%
CLDX0.27000.01003.85
AAPL154.941.87001.22
GOOG1 080.973.82000.35
MSFT105.380.37000.35
XOM71.64-0.0300-0.04
WFC48.941.27002.66
JNJ128.04-1.3200-1.02
FB147.54-1.4100-0.95
GE8.980.25002.86
JPM102.500.82000.81
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
6.50
Current Ratio
6.60
Long Term Debt to Total Capital
-
Total Debt to Equity
0.03
Interest Coverage
-
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-543.10
EBITDA Margin
-504.50
Pre-tax Profit Margin
-1 869.80
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
0.35
PS Ratios
5.77
Price to Cash Flow
8.30
Price to Free Cash Flow
-0.70
Cash Flow Per Share
-0.54
Price to Tangible Book
0.57
Book Value per Share
0.74
Enterprise Value (in ths.)
-60 725
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-43.76
ROE last 12 Months
-83.86
Return on Assets (5Y Avg)
-44.98
ROA last 12 Months
-59.72
Return on Capital (5Y Avg)
-42.68
ROC last 12 Months
-83.86
Return on invested Capital Q
-5.65
Return on invested Capital Y
-36.13
Assets Turnover
0.00
Receivables Turnover
1.40
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
7 774
Revenue per Share
0.05
Revenue Growth 3 Years
19.79
Revenue Growth 5 Years
22.43
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.15-0.0846.67
Q02 2018-0.14-0.1121.43
Q01 2018-0.17-0.19-11.76
Q04 2017-0.23-0.1726.09
Q03 2017-0.24-0.1441.67
Q02 2017-0.25-0.238.00
Q01 2017-0.28-0.280.00
Q04 2016-0.34-0.3011.76
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.0811.11Positive
12/2018 QR-0.0918.18Positive
12/2018 FY-0.3911.36Positive
12/2019 FY-0.489.43Positive
Next Report Date6th Mar 2019
Estimated EPS Next Report-0.08
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume5 162 696
Shares Outstanding (in ths.)172 470
Trades Count4 234
Dollar Volume1 446 119
Avg. Volume1 897 319
Avg. Weekly Volume1 881 563
Avg. Monthly Volume2 119 316
Avg. Quarterly Volume1 843 203

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

78%22%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
1 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (50.00 %)
1 (50.00 %)
2 (66.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.33

There are no comments yet.

News